Eledon Pharmaceuticals (ELDN)
(Delayed Data from NSDQ)
$2.54 USD
-0.15 (-5.58%)
Updated Sep 29, 2025 04:00 PM ET
After-Market: $2.55 +0.01 (0.39%) 4:42 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ELDN 2.54 -0.15(-5.58%)
Will ELDN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELDN
Best Momentum Stocks to Buy for July 14th
New Strong Buy Stocks for July 14th
ELDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock
Other News for ELDN
Is ELDN primed for upward momentum? Crossed Above 20 Day Moving Average shows up after soaring 8.91%
ELDN forms 20 Day Moving Average Resistance on September 26
Is ELDN gaining bearish strength? 20 Day Moving Average Resistance shows up after crashing 5.1%
Is ELDN lining up for a decline? Fell Below 20 Day Moving Average shows up after slipping 1.92%
ELDN Crossed Above 20 Day Moving Average on September 23